Today, the Greek Institute of Pharmaceutical Research and Technology (IFET) is expected to receive 2,000 doses of monoclonal antibodies.
Greece participates in the EU program for the supply of this treatment. The administration of monoclonal antibodies will be done according to specific medical criteria, examined by the Infection Committee, from the hospitals of the country.
Monoclonal antibodies cannot be administered to all patients with Covid-19.
The goal of this treatment is to prevent the disease from getting worse. Monoclonal antibodies are proteins designed in the laboratory to mimic the ability of the immune system to fight the coronavirus.
They attach to the SARS-CoV-2 spike protein, preventing the virus from entering human cells.
At the same time, the procedures for the supply of the antiviral pill of the Merck company are progressing.
However, experts emphasize that the existence of good and effective drugs does not eliminate the need for vaccination.
